Work

Phase I/II Study of Vaccination With Electrofused Allogeneic Dendritic Cells/Autologous Tumor-derived Cells in Patients With Stage IV Renal Cell Carcinoma

Year: 2007

Type: article

Study design: Clinical Trial

Source: Journal of Immunotherapy

DOI: 10.1097/cji.0b013e3180de4ce8

Authors: David E. Avigan, Baldev Vasir, Daniel J. George, William K. Oh, Michael B. Atkins, David F. McDermott, Philip W. Kantoff, Robert A. Figlin, Michael J. Vasconcelles, Yuanxin Xu, Donald Kufe, Ronald M. Bukowski

Institutions: Beth Israel Deaconess Medical Center, Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, University of California, Los Angeles, Cleveland Clinic

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2000274253

FWCI: 5.814

Cites: 56

Cited by: 119

Related to: 10